Company intelligence / Profile preview
Postbiotica
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
Overview
Postbiotica is an Italian biotechnology company specializing in the development and production of postbiotics, which are bioactive compounds generated during the fermentation of microorganisms. Utilizing its proprietary PB-Tech platform, the company creates standardized, non-living microbial derivatives that offer therapeutic benefits without the stability and safety issues often associated with live probiotics. Postbiotica's portfolio primarily targets the skincare and nutraceutical markets, focusing on applications for skin health, immune modulation, and gut wellness. The company operates as a spin-off from Humanitas University and collaborates with industrial partners to integrate its postbiotic ingredients into consumer products and therapeutic formulations.
- Therapeutic areas
- ImmunologyDermatologyGastroenterology
- Modalities
- Microbial therapyBiologicPeptides
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Postbiotica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Postbiotica.